Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01148420 · ClinicalTrials.gov registry record · Phase 4
DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding
A Phase 4 study of Dysfunctional Uterine Bleeding, sponsored by Women's Health Care Clinic, Torrance, California.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT01148420: Completed Phase 4 study of Dysfunctional Uterine Bleeding, sponsored by Women's Health Care Clinic, Torrance, California.
NCT01148420 is a Phase 4 study of Dysfunctional Uterine Bleeding that has completed, run by Women's Health Care Clinic, Torrance, California. The registered enrollment target is 48 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01148420, a Phase 4 study of Dysfunctional Uterine Bleeding, has completed, sponsored by Women's Health Care Clinic, Torrance, California.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the effectiveness and acceptability of high dose MPA (20mg oral 3 times a day) for 3 days combined with an injection of DMPA 150 mg intramuscularly in the treatment of acute heavy, prolonged uterine bleeding who have been identified as being eligible for outpatient management
Primary Outcome
Patients were called within 24 hours and 48 hours following their first study visit to ascertain their bleeding status and their use of medication, as well as any significant side effects they msy have been experiencing. Patients were asked to return to the clinic on day 3 for a repeat hemoglobin and interval history. Those women who were still having any bleeding on day 3 were contacted on day 5
Conditions Studied
Interventions
- DRUG Medroxyprogesterone 17-Acetate
- DRUG medroxyprogesterone acetate
Study Locations (1)
California
- Harbor-UCLA Urgent Care - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2009-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 4 |
What the finished NCT01148420 record still lists
NCT01148420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Dysfunctional Uterine Bleeding appearing as the primary indexed condition, and to 2 interventions - of which Medroxyprogesterone 17-Acetate is the first listed.
NCT01148420 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01148420 about?
NCT01148420 is a clinical study titled "DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding". The purpose of this study is to investigate the effectiveness and acceptability of high dose MPA (20mg oral 3 times a day) for 3 days combined with an injection of DMPA 150 mg intramuscularly in the treatment of acute heavy, prolonged uterine bleeding who have been identified as being eligible for o...
What is the current status of trial NCT01148420?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2009-01. Estimated completion is 2012-07.
What conditions does trial NCT01148420 study?
This clinical trial studies the following conditions: Dysfunctional Uterine Bleeding.
What interventions are being tested in trial NCT01148420?
The interventions under investigation include: Medroxyprogesterone 17-Acetate (DRUG), medroxyprogesterone acetate (DRUG).
Who is sponsoring clinical trial NCT01148420?
This trial is sponsored by Women's Health Care Clinic, Torrance, California, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01148420 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01148420's enrollment target sits among peer trials
48 1331st of 2000 higher than 653 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia